WallStreetZen

NASDAQ: MRNA
Moderna Inc Stock Forecast, Predictions & Price Target

Analyst price target for MRNA

Based on 9 analysts offering 12 month price targets for Moderna Inc.
Min Forecast
$80.00-76.53%
Avg Forecast
$225.56-33.83%
Max Forecast
$463.00+35.82%

Should I buy or sell MRNA stock?

Based on 13 analysts offering ratings for Moderna Inc.
Buy
Strong Buy
5 analysts 38.46%
Buy
0 analysts 0%
Hold
6 analysts 46.15%
Sell
2 analysts 15.38%
Strong Sell
0 analysts 0%

MRNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDate
Anonymous
Deutsche Bank
Strong SellInitiates Coverage On$250.00-26.66%2021-10-22
Piper Sandler
Top 17%
84
Strong BuyUpgradesN/AN/A2021-10-15
Morgan Stanley
Top 15%
86
HoldMaintains$337.00-1.14%2021-09-07
Barclays
Top 21%
80
Strong BuyMaintains$463.00+35.82%2021-08-06
Oppenheimer
Top 39%
62
HoldDowngradesN/AN/A2021-08-06
Jefferies
Top 13%
88
HoldMaintains$250.00-26.66%2021-07-15
Argus Research
Top 13%
88
Strong BuyMaintains$230.00-32.53%2021-06-24
Chardan Capital
Top 18%
83
Strong BuyMaintains$188.00-44.85%2021-05-07
Goldman Sachs
Top 14%
87
Strong BuyMaintains$228.00-33.11%2021-05-07
Wells Fargo
Top 35%
66
HoldMaintains$145.00-57.46%2021-02-01

1 of 2

Forecast return on equity

Is MRNA forecast to generate an efficient return?
Company
7.23%
Industry
18%
Market
16.16%
MRNA's Return on Equity is forecast to be low in 3 years (7.23%); analysts are not confident in the firm's ability to efficiently generate return on equity
Forecast

Forecast return on assets

Is MRNA forecast to generate an efficient return on assets?
Company
3%
Industry
6.54%
MRNA is forecast to generate lower Return on Assets (3%) than the US Biotechnology industry average (6.54%)
Forecast

MRNA earnings per share forecast

What is MRNA's earnings per share in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$29.17+235.67%
Avg 2 year Forecast
$25.41+192.41%
Avg 3 year Forecast
$15.26+75.6%
MRNA's earnings are forecast to grow at an exceptional rate of 25.66% per year
Forecast

MRNA revenue forecast

What is MRNA's revenue in the next 3 years based on estimates from 9 analysts?
Avg 1 year Forecast
$20.1B+186.93%
Avg 2 year Forecast
$21.1B+200.87%
Avg 3 year Forecast
$12.7B+81.14%
MRNA's revenue is forecast to grow at an exceptional rate of 28.46% per year
Forecast

MRNA earnings growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
25.66%
Industry
34.4%
Market
17.18%
MRNA's earnings are forecast to grow slower (25.66% per year) than the US Biotechnology industry average (34.4%)
Forecast
MRNA's earnings are forecast to grow faster (25.66% per year) than the US market average (17.18%)
Forecast
MRNA's earnings are forecast to grow faster (25.66% per year) than the risk-free savings rate (1.5%)
Forecast

MRNA revenue growth forecast

How is MRNA forecast to perform vs Biotechnology companies and vs the US market?
Company
28.46%
Industry
45.78%
Market
11.34%
MRNA's revenues are forecast to grow slower (28.46% per year) than the US Biotechnology industry average (45.78%)
Forecast
MRNA's revenues are forecast to grow faster (28.46% per year) than the US market average (11.34%)
Forecast

Moderna Stock Forecast FAQ

Is Moderna Stock a good buy in 2021, according to Wall Street analysts?

The consensus among 13 Wall Street analysts covering (NASDAQ: MRNA) stock is to Buy MRNA stock.

Out of 13 analysts, 5 (38.46%) are recommending MRNA as a Strong Buy, 0 (0%) are recommending MRNA as a Buy, 6 (46.15%) are recommending MRNA as a Hold, 2 (15.38%) are recommending MRNA as a Sell, and 0 (0%) are recommending MRNA as a Strong Sell.

What is MRNA's earnings growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual earnings growth rate of 25.66% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 34.4%, and while it is forecast to beat the US market's average forecast earnings growth rate of 17.18%.

Moderna's earnings in 2021 is $3,494,879,000.On average, 9 Wall Street analysts forecast MRNA's earnings for 2021 to be $11,774,362,921, with the lowest MRNA earnings forecast at $9,659,256,246, and the highest MRNA earnings forecast at $13,320,328,296. On average, 9 Wall Street analysts forecast MRNA's earnings for 2022 to be $10,256,652,788, with the lowest MRNA earnings forecast at $4,601,567,957, and the highest MRNA earnings forecast at $18,991,558,980.

In 2023, MRNA is forecast to generate $6,159,642,721 in earnings, with the lowest earnings forecast at $-1,844,663,646 and the highest earnings forecast at $13,078,140,509.

What is MRNA's revenue growth forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's forecast annual revenue growth rate of 28.46% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.78%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.34%.

Moderna's revenue in 2021 is $7,019,655,000.On average, 9 Wall Street analysts forecast MRNA's revenue for 2021 to be $8,130,167,323,505, with the lowest MRNA revenue forecast at $6,878,900,084,473, and the highest MRNA revenue forecast at $8,524,622,608,980. On average, 9 Wall Street analysts forecast MRNA's revenue for 2022 to be $8,525,099,315,275, with the lowest MRNA revenue forecast at $5,080,978,681,562, and the highest MRNA revenue forecast at $13,578,661,935,680.

In 2023, MRNA is forecast to generate $5,132,385,461,273 in revenue, with the lowest revenue forecast at $1,609,741,492,256 and the highest revenue forecast at $9,151,295,617,750.

What is MRNA's forecast return on assets (ROA) for 2021-2024?

(NASDAQ: MRNA) forecast ROA is 3%, which is lower than the forecast US Biotechnology industry average of 6.54%.

What is MRNA's Price Target?

According to 9 Wall Street analysts that have issued a 1 year MRNA price target, the average MRNA price target is $225.56, with the highest MRNA stock price forecast at $463.00 and the lowest MRNA stock price forecast at $80.00.

On average, Wall Street analysts predict that Moderna's share price could stay at $225.56 by Oct 15, 2022. The average Moderna stock price prediction forecasts a potential downside of N/A from the current MRNA share price of $340.88.

What is MRNA's Earnings Per Share (EPS) forecast for 2021-2023?

(NASDAQ: MRNA) Moderna's current Earnings Per Share (EPS) is $8.69. On average, analysts forecast that MRNA's EPS will be $29.17 for 2021, with the lowest EPS forecast at $23.93, and the highest EPS forecast at $33.00. On average, analysts forecast that MRNA's EPS will be $25.41 for 2022, with the lowest EPS forecast at $11.40, and the highest EPS forecast at $47.05. In 2023, MRNA's EPS is forecast to hit $15.26 (min: $-4.57, max: $32.40).

What is MRNA's forecast return on equity (ROE) for 2021-2024?

(NASDAQ: MRNA) forecast ROE is 7.23%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.